NO20004517D0 - Benzofurylpyron-derivater - Google Patents
Benzofurylpyron-derivaterInfo
- Publication number
- NO20004517D0 NO20004517D0 NO20004517A NO20004517A NO20004517D0 NO 20004517 D0 NO20004517 D0 NO 20004517D0 NO 20004517 A NO20004517 A NO 20004517A NO 20004517 A NO20004517 A NO 20004517A NO 20004517 D0 NO20004517 D0 NO 20004517D0
- Authority
- NO
- Norway
- Prior art keywords
- carbon
- carbons
- alkyl group
- benzofurylpyron
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Farming Of Fish And Shellfish (AREA)
- External Artificial Organs (AREA)
- Furan Compounds (AREA)
- Luminescent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6135698 | 1998-03-12 | ||
| PCT/JP1999/001225 WO1999046262A1 (fr) | 1998-03-12 | 1999-03-12 | Derives de benzofurylpyrone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004517D0 true NO20004517D0 (no) | 2000-09-11 |
| NO20004517L NO20004517L (no) | 2000-09-11 |
Family
ID=13168805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004517A NO20004517L (no) | 1998-03-12 | 2000-09-11 | Benzofurylpyron-derivater |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6589984B1 (no) |
| EP (1) | EP1063235B1 (no) |
| JP (1) | JP3922884B2 (no) |
| KR (1) | KR100595332B1 (no) |
| CN (1) | CN1170827C (no) |
| AT (1) | ATE266659T1 (no) |
| AU (1) | AU756965B2 (no) |
| BG (1) | BG104761A (no) |
| BR (1) | BR9908706A (no) |
| CA (1) | CA2323456A1 (no) |
| DE (1) | DE69917237T2 (no) |
| EE (1) | EE200000504A (no) |
| HR (1) | HRP20000600A2 (no) |
| HU (1) | HUP0101381A3 (no) |
| ID (1) | ID27511A (no) |
| IL (1) | IL138279A0 (no) |
| IS (1) | IS5617A (no) |
| NO (1) | NO20004517L (no) |
| NZ (1) | NZ506802A (no) |
| PL (1) | PL343419A1 (no) |
| RU (1) | RU2199536C2 (no) |
| SK (1) | SK13412000A3 (no) |
| TR (1) | TR200002642T2 (no) |
| UA (1) | UA58587C2 (no) |
| WO (1) | WO1999046262A1 (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID27511A (id) * | 1998-03-12 | 2001-04-12 | Teijin Ltd | Turunan-turunan benzofurilpiron |
| EP1351946A2 (en) * | 2000-09-01 | 2003-10-15 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| DE10115408A1 (de) * | 2001-03-29 | 2002-10-02 | Bayer Ag | Benzofuran-Derivate |
| BR0307944A (pt) * | 2002-02-25 | 2005-02-01 | Kudos Pharm Ltd | Piranonas úteis como inibidores de atm |
| DE10314610A1 (de) | 2003-04-01 | 2004-11-04 | Aventis Pharma Deutschland Gmbh | Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007063671A1 (de) * | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| FR2929276B1 (fr) * | 2008-04-01 | 2010-04-23 | Servier Lab | Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP2310372B1 (en) | 2008-07-09 | 2012-05-23 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| US8785608B2 (en) | 2009-08-26 | 2014-07-22 | Sanofi | Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| DE102014214016A1 (de) | 2014-07-18 | 2015-11-05 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Leichtbaustruktur und Verfahren zur Herstellung einer Leichtbaustruktur |
| US11433047B2 (en) * | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668803A (en) * | 1984-05-10 | 1987-05-26 | Atlantic Richfield Company | Benzafuran derivatives |
| DE4308451A1 (de) | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US5808062A (en) | 1993-11-19 | 1998-09-15 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| ID27511A (id) * | 1998-03-12 | 2001-04-12 | Teijin Ltd | Turunan-turunan benzofurilpiron |
-
1999
- 1999-03-12 ID IDW20001761A patent/ID27511A/id unknown
- 1999-03-12 DE DE69917237T patent/DE69917237T2/de not_active Expired - Fee Related
- 1999-03-12 JP JP2000535641A patent/JP3922884B2/ja not_active Expired - Fee Related
- 1999-03-12 HU HU0101381A patent/HUP0101381A3/hu unknown
- 1999-03-12 RU RU2000125690/04A patent/RU2199536C2/ru not_active IP Right Cessation
- 1999-03-12 PL PL99343419A patent/PL343419A1/xx not_active Application Discontinuation
- 1999-03-12 KR KR1020007010037A patent/KR100595332B1/ko not_active IP Right Cessation
- 1999-03-12 NZ NZ506802A patent/NZ506802A/xx unknown
- 1999-03-12 CA CA002323456A patent/CA2323456A1/en not_active Abandoned
- 1999-03-12 TR TR2000/02642T patent/TR200002642T2/xx unknown
- 1999-03-12 IL IL13827999A patent/IL138279A0/xx unknown
- 1999-03-12 US US09/646,005 patent/US6589984B1/en not_active Expired - Fee Related
- 1999-03-12 CN CNB99805917XA patent/CN1170827C/zh not_active Expired - Fee Related
- 1999-03-12 EE EEP200000504A patent/EE200000504A/xx unknown
- 1999-03-12 EP EP99939191A patent/EP1063235B1/en not_active Expired - Lifetime
- 1999-03-12 SK SK1341-2000A patent/SK13412000A3/sk unknown
- 1999-03-12 AU AU32773/99A patent/AU756965B2/en not_active Ceased
- 1999-03-12 AT AT99939191T patent/ATE266659T1/de not_active IP Right Cessation
- 1999-03-12 BR BR9908706-5A patent/BR9908706A/pt not_active IP Right Cessation
- 1999-03-12 WO PCT/JP1999/001225 patent/WO1999046262A1/ja not_active Application Discontinuation
- 1999-12-03 UA UA2000105676A patent/UA58587C2/uk unknown
-
2000
- 2000-09-08 IS IS5617A patent/IS5617A/is unknown
- 2000-09-11 NO NO20004517A patent/NO20004517L/no unknown
- 2000-09-12 HR HR20000600A patent/HRP20000600A2/hr not_active Application Discontinuation
- 2000-09-12 BG BG104761A patent/BG104761A/xx unknown
-
2003
- 2003-05-12 US US10/435,746 patent/US20030186976A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BG104761A (en) | 2001-08-31 |
| TR200002642T2 (tr) | 2001-01-22 |
| WO1999046262A1 (fr) | 1999-09-16 |
| IS5617A (is) | 2000-09-08 |
| IL138279A0 (en) | 2001-10-31 |
| KR20010041776A (ko) | 2001-05-25 |
| NO20004517L (no) | 2000-09-11 |
| HUP0101381A3 (en) | 2002-06-28 |
| AU3277399A (en) | 1999-09-27 |
| BR9908706A (pt) | 2000-11-21 |
| JP3922884B2 (ja) | 2007-05-30 |
| HUP0101381A2 (hu) | 2002-05-29 |
| UA58587C2 (uk) | 2003-08-15 |
| EP1063235A4 (en) | 2003-01-07 |
| KR100595332B1 (ko) | 2006-07-03 |
| RU2199536C2 (ru) | 2003-02-27 |
| PL343419A1 (en) | 2001-08-13 |
| US6589984B1 (en) | 2003-07-08 |
| EP1063235A1 (en) | 2000-12-27 |
| AU756965B2 (en) | 2003-01-30 |
| ATE266659T1 (de) | 2004-05-15 |
| DE69917237T2 (de) | 2005-05-04 |
| US20030186976A1 (en) | 2003-10-02 |
| CA2323456A1 (en) | 1999-09-16 |
| SK13412000A3 (sk) | 2001-04-09 |
| CN1170827C (zh) | 2004-10-13 |
| DE69917237D1 (de) | 2004-06-17 |
| ID27511A (id) | 2001-04-12 |
| HRP20000600A2 (en) | 2001-06-30 |
| NZ506802A (en) | 2002-11-26 |
| EE200000504A (et) | 2002-02-15 |
| CN1299359A (zh) | 2001-06-13 |
| EP1063235B1 (en) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE266659T1 (de) | Benzofurylpyron-derivate | |
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| ATE161848T1 (de) | Glycyrrheticsäurederivate | |
| ATE231142T1 (de) | Cyclopropachromencarbonsäure derivate | |
| ATE109770T1 (de) | Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten. | |
| NO872004L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4(5)-substituerte imidazol-derivater. | |
| ES2091283T3 (es) | Derivados de isocromano. | |
| DE69222076T2 (de) | Benzothiazolederivate | |
| ATE96800T1 (de) | Macrolid-derivate. | |
| NZ511572A (en) | Eudesmadienolide derivatives useful as glucose and lipid lowering compounds | |
| ES2019101B3 (es) | Compuestos aromaticos heteropoliciclicos. | |
| ATE112682T1 (de) | Isocarbacyclinderivate enthaltende antidiabetika. | |
| DE69303847D1 (de) | Indolderivate | |
| TW353071B (en) | Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions |